Next Due Date June 19, 2015; Submit Your Letter of Intent by May 19, 2015 Informational Webinar Coming Soon – Stay Tuned!
NHLBI’s Phase IIB Bridge Award provides up to $3M to support the continued development of your innovative technology requiring regulatory oversight. Applicants are expected to leverage NHLBI funding to attract matching third-party financing. For NHLBI-related technologies focused on rare diseases or pediatric populations, the Phase IIB Small Market Award (RFA-HL-14-012) provides up to $3M, with an expectation of partial matching funds from third-party investors. The next due date for RFA-HL-14-012 is June 19, 2015. Both Phase IIB programs are open to Phase II SBIR or STTR awardees from any agency.
{iframe}http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-16-009.html{/iframe}